119th Congress
S. 4332
Medication Competition Act
- Introduced
- In committee
- Passed Senate
- Passed House
- To President
- Became law
- Sponsor
- Margaret Wood Hassan(D-NH)
- Introduced
- Apr 16, 2026
- Policy area
- Health
- Committees
- Senate Committee on Health, Education, Labor, and Pensions
- Official text
- Introduced in Senate · Congress.gov page
Cosponsors (1)
Original cosponsors (1)
- Ted Budd (R-NC)
Summary
No Congressional Research Service summary yet. CRS usually publishes one a few weeks after a bill is introduced.
Official title: A bill to require the Secretary of Health and Human Services to make determinations of the exclusivity periods for which licensed biological products are eligible.
Latest action(Apr 16, 2026): Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Roll-call votes
No recorded votes on this bill.
Actions
- Apr 16, 2026 · Senate
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. - Apr 16, 2026
Introduced in Senate